Pacli (Paclitaxel)

Paclitaxel, the active ingredient in Pacli, is a chemotherapy agent presented as a sterile powder for intravenous infusion use. It treats a variety of solid tumours and is administered under the supervision of oncologists in hospital settings.

GNH USA supplies Pacli as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Pacli is a taxane‑type chemotherapy drug that interferes ​with ​cell ​division ​in ​solid ​tumour ​pathways ​and ​is ​used for several ​clinical ​indications. - Breast ​of ​the ​patient ​with ​advanced ​disease : Ach ​          ​            i   i  i  i